Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23121374 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
Conditions: Secondary Hyperparathyroidism;   Chronic Kidney Disease
Interventions: Drug: Cinacalcet;   Drug: Placebo

Indicates status has not been verified in more than two years